Understanding What Is the New Opioid Free Pain Medication, Journavx (Suzetrigine)
•
3 min read
In January 2025, the U.S. Food and Drug Administration approved Journavx (suzetrigine), marking the first new oral non-opioid painkiller in over two decades. This groundbreaking development offers a long-awaited alternative for patients seeking what is the new opioid free pain medication to treat moderate to severe acute pain.
